Delivery of mRNA Vaccine with 1, 2-Diesters-Derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer Immunotherapy

Adv Healthc Mater. 2024 Feb;13(5):e2302691. doi: 10.1002/adhm.202302691. Epub 2023 Nov 29.

Abstract

Messenger RNA (mRNA) vaccine is explored as a promising strategy for cancer immunotherapy, but the side effects, especially the liver-related damage caused by LNP, raise concerns about its safety. In this study, a novel library of 248 ionizable lipids comprising 1,2-diesters is designed via a two-step process involving the epoxide ring-opening reaction with carboxyl group-containing alkyl chains followed by an esterification reaction with the tertiary amines. Owing to the special chemical structure of 1,2-diesters, the top-performing lipids and formulations exhibit a faster clearance rate in the liver, contributing to increased stability and higher safety compared with DLin-MC3-DMA. Moreover, the LNP shows superior intramuscular mRNA delivery and elicits robust antigen-specific immune activation. The vaccinations delivered by the LNP system suppress tumor growth and prolong survival in both model human papillomavirus E7 and ovalbumin antigen-expressing tumor models. Finally, the structure of lipids which enhances the protein expression in the spleen and draining lymph nodes compared with ALC-0315 lipid in Comirnaty is further optimized. In conclusion, the 1, 2-diester-derived lipids exhibit rapid liver clearance and effective anticancer efficiency to different types of antigens-expressing tumor models, which may be a safe and universal platform for mRNA vaccines.

Keywords: immunotherapy; lipid nanoparticle; mRNA delivery.

MeSH terms

  • Cancer Vaccines*
  • Humans
  • Lipids / chemistry
  • Liver / metabolism
  • Nanoparticles* / chemistry
  • Neoplasms*
  • RNA, Messenger / metabolism
  • Vaccination
  • mRNA Vaccines

Substances

  • mRNA Vaccines
  • RNA, Messenger
  • Cancer Vaccines
  • Lipids